Skip to main content
This link has been bookmarked by 1 people . It was first bookmarked on 24 Jul 2011, by avivajazz jazzaviva.
We found that 5% imiquimod cream is an effective treatment option for superficial and nodular basal cell carcinomas, giving a clearance rate of 89.5% at an average of 39 months of follow up.
BCC sBCC basal-cell-carcinoma basalcellcarcinoma treatment treatments skincancer skin-cancer therapy pubmed pubs trials clinicaltrials abstracts therapies imiquimod aldera aldara study studies
Join Diigo for a free account, or sign in if you are already a member.